Esprit BTK Post-Approval Study

Purpose

The Esprit BTK PAS is a prospective, single-arm, multi-center observational study to assess the continued safety and effectiveness of the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System under commercial use, in patients with diseased infrapopliteal lesions causing CLTI (Chronic Limb-Threatening Ischemia) in a real-world setting. The clinical investigation will be conducted at up to 50 sites in the United States (US) and additional sites may be added outside of the US (OUS). Approximately 200 patients with a minimum of 50% of patients in the US will be registered in the clinical investigation.

Condition

  • Chronic Limb-Threatening Ischemia

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • General Inclusion Criteria 1. Subject must provide written informed consent prior to any study-specific procedures which are not considered standard of care at the site. 1. Informed consent can be obtained up to 3 days post-procedure or prior to discharge whichever comes first. 2. Subject, or a legally acceptable representative must provide written informed consent per site IRB/EC requirements. 2. Subject must be at least 18 years of age. 3. Subject has evidence of symptomatic Chronic Limb-Threatening Ischemia (CLTI) with infrapopliteal lesions. - Anatomic Inclusion Criteria 1. Subjects who have lesion(s) in an infrapopliteal vessel with reference vessel diameter ≥ 2.5 mm and ≤ 4.0 mm. 2. Target lesion(s) must have ≥ 70% stenosis, per visual assessment at the time of the procedure. If needed, quantitative imaging (angiography and intravascular imaging) can be used to aid accurate sizing of the vessels.

Exclusion Criteria

  • General Exclusion Criteria 1. Subjects who have contraindications to the Esprit BTK System per the instruction for use (IFU). 2. Subject is currently participating in another clinical investigation. 3. Subject is unable or unwilling to provide written consent prior to enrollment. 4. Subject with life expectancy ≤ 1 year. 5. Subject with an unsalvageable limb (as per physician assessment at the time of the index procedure), who is likely to get a below-the-knee amputation. - Anatomic Exclusion Criteria 1. Subject has in-stent restenosis in the target vessel or requires treatment with a metallic stent in the target vessel during the index procedure. 2. Subject had been previously treated with Esprit BTK Scaffold(s).

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Esprit BTK System
This device, manufactured by Abbott Medical, is intended to be used for improving luminal diameter in infrapopliteal lesions in patients with CLTI.
  • Device: Esprit BTK System
    The Esprit BTK System is a resorbable polymeric scaffold with the everolimus drug and a resorbable polymeric coating mounted on a balloon dilatation catheter.

Recruiting Locations

HonorHealth
Scottsdale 5313457, Arizona 5551752 85258
Contact:
Kiersten Rundio, Ms
krundio@honorhealth.com

Pima Heart and Vascular Clinical Research
Tucson 5318313, Arizona 5551752 85718

UCSF Fresno
Fresno 5350937, California 5332921 93720
Contact:
Yeng Vue
yeng.vue@ucsf.edu

Good Samaritan Hospital
Los Angeles 5368361, California 5332921 90017
Contact:
Xochitl Quintero, Ms
Xochitl.Quintero@pihhealth.org

Washington Hospital Center
Washington D.C. 4140963, District of Columbia 4138106 20010
Contact:
Kassaye Sesaba
Kassaye.T.Sesaba@medstar.net

First Coast Cardiovascular Institute
Jacksonville 4160021, Florida 4155751 32256
Contact:
Alayna Socia
asocia@firstcoastcardio.com

Ansaarie Cardiac and Endovascular Center of Excellence
Saint Augustine 4170894, Florida 4155751 32080
Contact:
Genevieve Rexford
genevieverexford@ansaarie.com

Tallahassee Research Institute
Tallahassee 4174715, Florida 4155751 32308
Contact:
Brianna Everett
brianna.everett@tmh.org

Grady Clinical Research Center
Atlanta 4180439, Georgia 4197000 30303
Contact:
Ronnie Adams
rwadam2@emory.edu

Archbold Medical Center
Thomasville 4226348, Georgia 4197000 31792
Contact:
Krystal Twyman
krystal@ccsgheart.com

SIU School of Medicine
Springfield 4250542, Illinois 4896861 62794
Contact:
Kristal Adams
kadams@siumed.edu

St. Vincent Hospital
Indianapolis 4259418, Indiana 4921868 46260
Contact:
Allyn Harker
allyn.harker@ascension.org

Charlton Memorial Hospital
Fall River 4936159, Massachusetts 6254926 02720
Contact:
Debra Benevides
BenevidesD@southcoast.org

Jackson Heart Clinic
Jackson 4431410, Mississippi 4436296 39216
Contact:
Jamie Neal
jneal@jacksonheart.com

North Mississippi Medical Center
Tupelo 4448903, Mississippi 4436296 38801
Contact:
Amber Jernigan, Ms
anschmitz@nmhs.net

New York University Hospital
New York 5128581, New York 5128638 10016
Contact:
Oksana Lyzhyn
oksana.lyzhyn@nyulangone.org

Mount Sinai Hospital
New York 5128581, New York 5128638 10019
Contact:
Vanna Nicasio
Vanna.Nicasio@mountsinai.org

New York Presbyterian Hospital-Cornell University
New York 5128581, New York 5128638 10021
Contact:
Rosa Chu, Ms
roc2025@med.cornell.edu

New York-Presbyterian/Columbia University Medical Center
New York 5128581, New York 5128638 10032
Contact:
Suzanne Edwards
sme2146@cumc.columbia.edu

St. Francis Hospital
Roslyn 5134415, New York 5128638 11576
Contact:
Michele Piscitelli-Sharp
Michele.Piscitelli-Sharp@chsli.org

Staten Island University Hospital - North
Staten Island 5139568, New York 5128638 10305
Contact:
Brandon Dilluvio
bdilluvio@northwell.edu

Carolinas Medical Center
Charlotte 4460243, North Carolina 4482348 28203
Contact:
Madelyn Smyth
madelyn.smyth@atriumhealth.org

Christ Hospital
Cincinnati 4508722, Ohio 5165418 45255
Contact:
Brittney Hoeffler
brittney.hoeffler@thechristhospital.com

Ascension St. John Jane Phillips
Bartlesville 4529987, Oklahoma 4544379 74006
Contact:
Mary Harris, Ms
Mary.Harris5@ascension.org

Hightower Clinical
Oklahoma City 4544349, Oklahoma 4544379 73102
Contact:
Zac Johnson
zac@hightowerclinical.com

Oklahoma Heart Hospital
Oklahoma City 4544349, Oklahoma 4544379 73120
Contact:
Rebecca Straily
rstraily@okheart.com

Erlanger Medical Center
Chattanooga 4612862, Tennessee 4662168 37403
Contact:
Parvathikumari Kasa
Parvathikumari.Kasa@erlanger.org

Johnson City Medical Center Hospital
Johnson City 4633419, Tennessee 4662168 37604
Contact:
Charlie Mays
charles.mays@balladhealth.org

Hendrick Medical Center
Abilene 4669635, Texas 4736286 79601
Contact:
Katherine Schuessler
kmschuessler@hendrickhealth.org

University of Texas Southwestern Medical Center at Dallas
Dallas 4684888, Texas 4736286 75390
Contact:
Jarrett Hubbard
jarrett.hubbard@utsouthwestern.edu

Baylor All Saints Medical Center at Fort Worth
Fort Worth 4691930, Texas 4736286 76104
Contact:
Kylie Jefferson
kylie.jefferson@bswhealth.org

Park Plaza Hospital
Houston 4699066, Texas 4736286 77004
Contact:
Kayla Izaguirre
Kayla.Izaguirre@hcaHealthcare.com

More Details

NCT ID
NCT06656364
Status
Recruiting
Sponsor
Abbott Medical Devices

Study Contact

Anna Wong
+1 (408) 845-0846
anna.wong@abbott.com